REGENXBIO Inc (RGNX)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Dr. Stephen PakolaExec. VP & Chief Medical Officer | -15.31k | 168.71k | Automatic Disposition | 11.02 | 65.28k | -19.00% |
| 2026-03-10 | Dr. Stephen PakolaExec. VP & Chief Medical Officer | -5.12k | 53.03k | Automatic Disposition | 10.35 | 80.59k | -5.98% |
| 2026-02-01 | Dr. Stephen PakolaExec. VP & Chief Medical Officer | -5.27k | 58.78k | Sale to Issuer | 11.16 | 85.71k | -5.79% |
| 2026-02-01 | Mr. Patrick J. ChristmasExec. VP & Chief Strategy and Legal Officer | -4.70k | 52.45k | Sale to Issuer | 11.16 | 88.51k | -5.04% |
| 2026-01-27 | Mr. Kenneth T. MillsChairman | 3.25k | 42.50k | Derivative Exercise and Retained Stock | 13.09 | 432.61k | 0.76% |
| 2026-01-27 | Mr. Kenneth T. MillsChairman | -221.75k | 70.96k | Derivative Exercise and Sale | 13.09 - 13.41 | 432.61k | - |
| 2026-01-02 | Mr. Craig MalzahnExec. VP of Product Development & CTO | -1.24k | 17.83k | Sale to Issuer | 14.40 | 16.35k | -7.04% |
| 2026-01-02 | Mr. Curran M. SimpsonPresident, CEO & Director | -18.56k | 267.25k | Sale to Issuer | 14.40 | 44.86k | -29.27% |
| 2026-01-02 | Mr. Patrick J. ChristmasExec. VP & Chief Strategy and Legal Officer | -9.79k | 141.02k | Sale to Issuer | 14.40 | 79.10k | -11.02% |
| 2026-01-02 | Dr. Stephen PakolaExec. VP & Chief Medical Officer | -18.25k | 262.76k | Sale to Issuer | 14.40 | 76.39k | -19.28% |
| 2025-10-09 | Mr. Curran M. SimpsonPresident, CEO & Director | -20.81k | 262.63k | Automatic Disposition | 12.62 | 9.41k | -68.86% |
| 2025-09-29 | Mr. Curran M. SimpsonPresident, CEO & Director | -7.62k | 76.47k | Automatic Disposition | 10.03 | 30.22k | -20.14% |
| 2025-09-10 | Mr. Curran M. SimpsonPresident, CEO & Director | -7.73k | 77.49k | Automatic Disposition | 10.02 | 37.85k | -16.97% |
| 2025-09-01 | Mr. Craig MalzahnExec. VP of Product Development & CTO | -234.00 | 2.09k | Sale to Issuer | 8.93 | 17.59k | -1.31% |
| 2025-09-01 | Mr. Mitchell ChanExec. VP & CFO | -4.90k | 43.77k | Sale to Issuer | 8.93 | 9.82k | -33.30% |
| 2025-08-01 | Mr. Patrick J. ChristmasExec. VP & Chief Strategy and Legal Officer | -4.70k | 38.48k | Sale to Issuer | 8.19 | 61.28k | -7.12% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。